Literature DB >> 12885893

Identification of the E9/E2C cDNA and functional characterization of the gene product reveal a new repressor of transcription and replication in cottontail rabbit papillomavirus.

Sonja Jeckel1, Ekaterina Loetzsch, Evamaria Huber, Frank Stubenrauch, Thomas Iftner.   

Abstract

Cottontail rabbit papillomavirus (CRPV) genomes mutated in the trans-activation domain of the E2 protein, which stimulates both viral DNA replication and transcription, are severely impaired in their ability to induce tumors in New Zealand White rabbits. A number of papillomaviruses encode, in addition to full-length E2, a shortened E2 protein or an E2 protein fused to a short stretch of amino acids derived from the small E8 open reading frame that counteract the activities of E2. We identified and cloned the novel cDNA E9/E2C of CRPV from papillomas of New Zealand White and cottontail rabbits and characterized the functions of the encoded gene product. E9/E2C was shown to be a bona fide repressor of minimal viral promoters, with the E9 domain being essential for this activity, and to repress E1/E2-dependent replication of a CRPV origin construct. In addition, E9/E2C counteracted the transactivation effect of the full-length E2 on minimal promoters containing several E2 binding sites. To investigate the role of E9/E2C in tumorigenesis, we constructed two CRPV genomes mutated in E9/E2C. One, designated CRPV-E9atgmut-pLAII, contained a mutation in the unique start codon in the E9 open reading frame, and the second E9/E2C mutant was constructed by the introduction of a stop codon close to the splice donor site at nucleotide 3714 that additionally prevented the correct splicing of the transcript. When we infected New Zealand White rabbits with these constructs, we surprisingly noted no differences in tumor induction efficiency, viral genome copy number, and viral transcription in comparison to wild-type CRPV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885893      PMCID: PMC167252          DOI: 10.1128/jvi.77.16.8736-8744.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Characterization of rare human papillomavirus type 11 mRNAs coding for regulatory and structural proteins, using the polymerase chain reaction.

Authors:  M O Rotenberg; L T Chow; T R Broker
Journal:  Virology       Date:  1989-10       Impact factor: 3.616

2.  Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.

Authors:  F Stubenrauch; A M Colbert; L A Laimins
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  Genetic assignment of multiple E2 gene products in bovine papillomavirus-transformed cells.

Authors:  P F Lambert; N L Hubbert; P M Howley; J T Schiller
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

4.  A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator.

Authors:  P F Lambert; B A Spalholz; P M Howley
Journal:  Cell       Date:  1987-07-03       Impact factor: 41.582

5.  Competition for DNA binding sites between the short and long forms of E2 dimers underlies repression in bovine papillomavirus type 1 DNA replication control.

Authors:  D A Lim; M Gossen; C W Lehman; M R Botchan
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain.

Authors:  A A McBride; J C Byrne; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

7.  Genetic analysis of CRPV pathogenesis: the L1 open reading frame is dispensable for cellular transformation but is required for papilloma formation.

Authors:  M Nasseri; C Meyers; F O Wettstein
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

8.  Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients.

Authors:  R J Berkhout; L M Tieben; H L Smits; J N Bavinck; B J Vermeer; J ter Schegget
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

Review 9.  Viruses in human cancers.

Authors:  H zur Hausen
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

10.  Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies.

Authors:  M T Chin; R Hirochika; H Hirochika; T R Broker; L T Chow
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more
  25 in total

1.  Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression.

Authors:  Jasmin Fertey; Ingo Ammermann; Michael Winkler; Reinhard Stöger; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

2.  Brd4 links chromatin targeting to HPV transcriptional silencing.

Authors:  Shwu-Yuan Wu; A-Young Lee; Samuel Y Hou; Jongsook Kim Kemper; Hediye Erdjument-Bromage; Paul Tempst; Cheng-Ming Chiang
Journal:  Genes Dev       Date:  2006-08-18       Impact factor: 11.361

Review 3.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

4.  A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivo.

Authors:  Natalie Leiprecht; Ekaterina Notz; Johanna Schuetz; Juliane Haedicke; Frank Stubenrauch; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

5.  Orf Virus-Based Therapeutic Vaccine for Treatment of Papillomavirus-Induced Tumors.

Authors:  M Schneider; M Müller; A Yigitliler; J Xi; C Simon; T Feger; H-J Rziha; F Stubenrauch; H-G Rammensee; T Iftner; R Amann
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

Review 6.  Involvement of Brd4 in different steps of the papillomavirus life cycle.

Authors:  Thomas Iftner; Juliane Haedicke-Jarboui; Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  Virus Res       Date:  2016-12-10       Impact factor: 3.303

7.  Inhibition of transcription and DNA replication by the papillomavirus E8-E2C protein is mediated by interaction with corepressor molecules.

Authors:  Ingo Ammermann; Markus Bruckner; Frank Matthes; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

8.  The viral E8^E2C repressor limits productive replication of human papillomavirus 16.

Authors:  Elke Straub; Marcel Dreer; Jasmin Fertey; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

9.  Mapping of betapapillomavirus human papillomavirus 5 transcription and characterization of viral-genome replication function.

Authors:  Eve Sankovski; Andres Männik; Jelizaveta Geimanen; Ene Ustav; Mart Ustav
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

10.  Characterization of the nuclear matrix targeting sequence (NMTS) of the BPV1 E8/E2 protein--the shortest known NMTS.

Authors:  Eve Sankovski; Kristiina Karro; Mari Sepp; Reet Kurg; Mart Ustav; Aare Abroi
Journal:  Nucleus       Date:  2015       Impact factor: 4.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.